- News
- Events
At the esteemed 2024 BioCapital Europe Investor Conference, Noselab GmbH made waves with its revolutionary diagnostic breakthrough. CEO Thomas Heydler revealed their groundbreaking proprietary diagnostic platform, aiming to transform the lives of patients with neurodegenerative diseases (ND), with an initial focus on Alzheimer’s Disease.